Rhumbline Advisers 10x Genomics, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 108,116 shares of TXG stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,116
Previous 109,757 1.5%
Holding current value
$1.62 Million
Previous $2.48 Million 37.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$13.18 - $21.31 $21,628 - $34,969
-1,641 Reduced 1.5%
108,116 $1.55 Million
Q3 2024

Nov 12, 2024
BUY
$15.71 - $23.49 $43,752 - $65,419
2,785 Added 2.6%
109,757 $2.48 Million
Q2 2024

Aug 01, 2024
BUY
$19.45 - $37.37 $1,264 - $2,429
65 Added 0.06%
106,972 $2.08 Million
Q1 2024

May 09, 2024
SELL
$36.08 - $54.3 $540,298 - $813,142
-14,975 Reduced 12.29%
106,907 $4.01 Million
Q4 2023

Feb 08, 2024
BUY
$34.32 - $57.55 $16,302 - $27,336
475 Added 0.39%
121,882 $6.82 Million
Q3 2023

Nov 09, 2023
BUY
$40.86 - $62.98 $29,337 - $45,219
718 Added 0.59%
121,407 $5.01 Million
Q2 2023

Aug 08, 2023
BUY
$50.96 - $58.72 $627,878 - $723,489
12,321 Added 11.37%
120,689 $6.74 Million
Q1 2023

May 11, 2023
BUY
$35.33 - $55.79 $248,687 - $392,705
7,039 Added 6.95%
108,368 $6.05 Million
Q4 2022

Feb 14, 2023
BUY
$24.4 - $41.3 $140,910 - $238,507
5,775 Added 6.04%
101,329 $3.69 Million
Q3 2022

Nov 10, 2022
BUY
$28.48 - $52.59 $311,001 - $574,282
10,920 Added 12.9%
95,554 $2.72 Million
Q2 2022

Aug 11, 2022
BUY
$36.95 - $82.41 $497,236 - $1.11 Million
13,457 Added 18.91%
84,634 $3.83 Million
Q1 2022

May 12, 2022
SELL
$55.7 - $145.79 $418,919 - $1.1 Million
-7,521 Reduced 9.56%
71,177 $5.41 Million
Q4 2021

Feb 10, 2022
BUY
$135.05 - $182.59 $352,075 - $476,012
2,607 Added 3.43%
78,698 $11.7 Million
Q3 2021

Nov 12, 2021
SELL
$145.58 - $192.14 $109,039 - $143,912
-749 Reduced 0.97%
76,091 $11.1 Million
Q2 2021

Aug 05, 2021
BUY
$134.22 - $202.37 $2.6 Million - $3.92 Million
19,354 Added 33.67%
76,840 $15 Million
Q1 2021

May 06, 2021
SELL
$140.25 - $196.86 $155,537 - $218,317
-1,109 Reduced 1.89%
57,486 $10.4 Million
Q4 2020

Feb 10, 2021
SELL
$126.47 - $163.7 $44,138 - $57,131
-349 Reduced 0.59%
58,595 $8.3 Million
Q3 2020

Nov 12, 2020
SELL
$87.44 - $125.0 $112,098 - $160,250
-1,282 Reduced 2.13%
58,944 $7.35 Million
Q2 2020

Aug 13, 2020
BUY
$58.39 - $89.31 $3.52 Million - $5.38 Million
60,226 New
60,226 $5.38 Million

Others Institutions Holding TXG

# of Institutions
289
Shares Held
95.8M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.43B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email